Literature DB >> 35069032

Acute Severe Colitis: The Need for Joint Management between Gastroenterologists and Surgeons.

Phillip Fleshner1, Gil Y Melmed1.   

Abstract

The management of hospitalized patients with acute, severe ulcerative colitis involves close coordination among a multidisciplinary team. For patients not improving on intravenous corticosteroids, surgical consultation should be sought. The remaining hospital course requires frequent communications between the gastroenterologist managing the medical aspects of care, and the colorectal surgeon involved in planning for potential surgery, to optimize patient outcomes. This comanagement includes joint decision-making around the timing of surgery, minimizing medications associated with postoperative morbidity, addressing nutritional and psychosocial aspects of the patient's condition, and planning for a coordinated postoperative course. In this review, we highlight these aspects of care and the need for coordination and communication between gastroenterologists and surgeons in the management of acute severe colitis. Thieme. All rights reserved.

Entities:  

Keywords:  acute; colectomy; ostomy; ulcerative colitis

Year:  2022        PMID: 35069032      PMCID: PMC8763454          DOI: 10.1055/s-0041-1740030

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  44 in total

1.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 2.  The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.

Authors:  Alastair Windsor; Pierre Michetti; Willem Bemelman; Subrata Ghosh
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

3.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

4.  The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.

Authors:  Daniel Mark Baker; Matthew James Lee; Georgina Louise Jones; Steven Ross Brown; Alan Joseph Lobo
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

5.  An evaluation of total parenteral nutrition in the management of inflammatory bowel disease.

Authors:  C O Elson; T J Layden; B A Nemchausky; J L Rosenberg; I H Rosenberg
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

6.  Prolonged Medical Therapy Increases the Risk of Surgical Complications in Patients with Severe Ulcerative Colitis.

Authors:  Hideaki Kimura; Reiko Kunisaki; Kenji Tatsumi; Kazutaka Koganei; Akira Sugita; Itaru Endo
Journal:  Dig Surg       Date:  2016-02-10       Impact factor: 2.588

7.  Management of acute, severe ulcerative colitis.

Authors:  David B Sachar
Journal:  J Dig Dis       Date:  2012-02       Impact factor: 2.325

8.  Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.

Authors:  Xavier Calvet; Julián Panés; Noelia Alfaro; Joaquin Hinojosa; Beatriz Sicilia; Marta Gallego; Ildefonso Pérez; Pablo Lázaro y de Mercado; Fernando Gomollón; Xavier Aldeguera; Rafael Alós; Montserrat Andreu; Manu Barreiro; Fernando Bermejo; Begoña Casis; Eugeni Domenech; Eloy Espín; Maria Esteve; Valle García-Sánchez; Antonio López-Sanromán; Pilar Martínez-Montiel; Juan Luis Mendoza; Javier P Gisbert; Maribel Vera; Angelina Dosal; Elena Sánchez; Laura Marín; Luciano Sanromán; Pilar Pinilla; Francisca Murciano; Antonio Torrejón; José Ramón García; Mayte Ortega; Julio Roldán
Journal:  J Crohns Colitis       Date:  2013-12-02       Impact factor: 9.071

9.  Patient and clinician preferences for surgical and medical treatment options in ulcerative colitis.

Authors:  C M Byrne; K-K Tan; J M Young; W Selby; M J Solomon
Journal:  Colorectal Dis       Date:  2014-04       Impact factor: 3.788

10.  Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.

Authors:  Jeong Yeon Kim; Karen Zaghiyan; Amy Lightner; Phillip Fleshner
Journal:  BMC Surg       Date:  2020-03-05       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.